Join the Fragmin group to help and get support from people like you.
Fragmin News
FDA Approves Fragmin (dalteparin sodium) as First Anticoagulant for Venous Thromboembolism in Pediatric Patients
May 16, 2019 – The U.S. Food and Drug Administration today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE)...
Further information
Related condition support groups
Angina, Deep Vein Thrombosis - Prophylaxis, Myocardial Infarction, Heart Attack